|
Volumn 2, Issue 2, 2002, Pages 17-19
|
Are concerns about the ethics of placebos a stalking horse for other issues?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDEPRESSANT AGENT;
PLACEBO;
ARTICLE;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROL GROUP;
CONTROLLED CLINICAL TRIAL;
DEPRESSION;
EMPIRICAL APPROACH;
ETHICS;
HUMAN;
MENTAL HEALTH THERAPIES;
METHODOLOGY;
PSYCHOLOGICAL ASPECT;
RANDOMIZED CONTROLLED TRIAL;
RESEARCH ETHICS;
STATISTICS;
SUICIDE;
WITHDRAWAL SYNDROME;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
EMPIRICAL APPROACH;
MENTAL HEALTH THERAPIES;
ANTIDEPRESSIVE AGENTS;
CONTROL GROUPS;
DEPRESSIVE DISORDER;
ETHICS, RESEARCH;
HUMANS;
PLACEBOS;
RANDOMIZED CONTROLLED TRIALS;
SUBSTANCE WITHDRAWAL SYNDROME;
SUICIDE;
|
EID: 0036516743
PISSN: 15265161
EISSN: 15360075
Source Type: Journal
DOI: 10.1162/152651602317533569 Document Type: Note |
Times cited : (4)
|
References (9)
|